课题基金 / 基金详情

In vitro and in vivo evaluation of a novel 68Ga-labeled BVD15 analogue for neuropeptide Y1 receptor imaging with positron emission tomography

In vitro and in vivo evaluation of a novel 68Ga-labeled BVD15 analogue for neuropeptide Y1 receptor imaging with positron emission tomography
新型 68Ga 标记的 BVD15 类似物用于正电子发射断层扫描神经肽 Y1 受体成像的体外和体内评估
批准号：
331941
负责人：
Zhang Chengcheng
金额：
$0.07万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-05-01 至 2016-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=331941&lang=en
关键词：
Breast Cancer Diagnostic Imaging Imaging Probe Evalution Imaging Probe Synthesis Molecular Biology Molecular Imaging Positron Emission Tomography

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is the second most common cancer worldwide with 1.68 million new cases and 522,000 deaths in 2012. Medical imaging-based diagnosis could help identify breast cancers at early stages, and substantially reduce mortality rate by providing early
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金